Kristin Meliambro

Icahn School Of Medicine At Mount Sinai

$2,184,634

Attributed

$2,765,882

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $986.2K · FY2018–25

$1M$750K$500K$250K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,765,882 · 3

By mechanism

R01$1,094,908 · 1

K08$895,976 · 1

U01$774,998 · 1

Top collaborators

Most similar at Icahn School Of Medicine At Mount Sinai

Same institution · by research overlap

Girish Nitin Nadkarni$10,989,187
Lewis Kaufman$8,156,411
Kirk N Campbell$10,746,650
Lili Chan$1,630,806
Ilse Sofia Daehn$7,432,625

Others in their field

Other Emerging Leaders on “Diabetic Nephropathy”

Ionut Bebu · George Washington University$14,825,594
Barbara Halina Braffett · George Washington University$14,825,594
Petter Bjornstad · University Of Colorado Denver$7,661,076
Kyung W Lee · Basic Sciences$3,933,699
Sunil Kannanganat Sidharthan · Astero Erado Inc$2,898,618
Pinaki Sarder · State University Of New York At Buffalo$2,897,139

Research focus

Diabetic NephropathyDisease ProgressionTherapeutic TargetKidneyPathway InteractionsTargeted TreatmentInjurySignaling ProteinRenal Glomerular DiseaseSignal PathwayIn VivoPhosphotransferasesFocal AdhesionsProteinsBrainDisease ModelActinsCellsFamilyChronicIn VitroGene ExpressionCytoskeletonPodocyte